SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-18 |
| Reported value | $188,517,817 |
| Positions | 14 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ArriVent BioPharma, Inc. | AVBP | COM | $51,928,866 | 1,494,786 |
| Parabilis Medicines, Inc. | PBLS | COM | $43,817,646 | 1,600,937 |
| Maplebear, Inc. | CART | COM | $33,652,166 | 710,711 |
| Maze Therapeutics, Inc. | MAZE | COM | $30,911,554 | 1,035,910 |
| Odyssey Therapeutics, Inc. | ODTX | COMMON STOCK | $15,160,189 | 810,272 |
| Eikon Therapeutics, Inc. | EIKN | COM | $3,983,291 | 305,233 |
| Fractyl Health, Inc. | GUTS | COM | $3,879,997 | 4,884,186 |
| Ethos Technologies, Inc. | LIFE | CL A | $1,345,607 | 74,179 |
| Coupang Inc. | CPNG | CL A | $949,739 | 54,677 |
| Amazon.com Inc. | AMZN | COM | $925,236 | 3,882 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.